Zobrazeno 1 - 10
of 258
pro vyhledávání: '"S S, Gottlieb"'
Autor:
N. K. Fukagawa, E. T. Poehlman, M. J. Toth, P. S. Fishman, P. Vaitkevicius, S. S. Gottlieb, M. L. Fisher, T. Fonong
Publikováno v:
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. :73-77
We examine the association of the menopause transition, congestive heart failure, and Parkinson's disease on body composition and energy expenditure. We present evidence suggesting that the normal menopausal transition is associated with accelerated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ef604fb1eb23a33cfeb7d234f1e5714
https://doi.org/10.1093/gerona/50a.special_issue.73
https://doi.org/10.1093/gerona/50a.special_issue.73
Autor:
S S, Gottlieb, R J, McCarter
Publikováno v:
The American journal of cardiology. 87(7)
The beneficial impact of beta blockade after an acute myocardial infarction (AMI) is clear, but beta-adrenergic blockers differ in multiple characteristics, including lipophilicity and selectivity. The impact of these factors on the effects of beta b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b4319670e40bde968a4e40f598c6dfb4
https://pubmed.ncbi.nlm.nih.gov/11274934
https://pubmed.ncbi.nlm.nih.gov/11274934
Autor:
M T, Slawsky, W S, Colucci, S S, Gottlieb, B H, Greenberg, E, Haeusslein, J, Hare, S, Hutchins, C V, Leier, T H, LeJemtel, E, Loh, J, Nicklas, D, Ogilby, B N, Singh, W, Smith
Publikováno v:
Circulation. 102(18)
We determined the short-term hemodynamic and clinical effects of levosimendan, a novel calcium-sensitizing agent, in patients with decompensated heart failure.One hundred forty-six patients with New York Heart Association functional class III or IV h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::771d0d56cbac09e8e4f06e40ef78d334
https://pubmed.ncbi.nlm.nih.gov/11056096
https://pubmed.ncbi.nlm.nih.gov/11056096
Autor:
S S, Gottlieb
Publikováno v:
The American journal of managed care. 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::02c157fe1d8bb257956c32baaf226fa8
https://pubmed.ncbi.nlm.nih.gov/11010424
https://pubmed.ncbi.nlm.nih.gov/11010424
Autor:
S, Goldstein, S S, Gottlieb
Publikováno v:
Journal of cardiac failure. 6(2 Suppl 1)
The beneficial effects of beta-adrenergic blockade on mortality rates in patients after a myocardial infarction have been clear for decades. The efficacy data are now just as apparent for patients with heart failure. Although there are many subgroups
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5b9ab6ba95b3b8da2b35fb61cd1bf3e
https://pubmed.ncbi.nlm.nih.gov/10908094
https://pubmed.ncbi.nlm.nih.gov/10908094
Publikováno v:
Pharmacotherapy. 17(4)
A patient with heart failure was administered d-sotalol 3.0 mg/kg infused over 2 minutes. The patient had normal electrolytes and baseline QT. Six minutes after drug administration the QT prolonged to 600 msec, and the patient developed torsades de p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fda644e747318afb4d0f630ec3bd9bf0
https://pubmed.ncbi.nlm.nih.gov/9250567
https://pubmed.ncbi.nlm.nih.gov/9250567
Autor:
M, Packer, W S, Colucci, J D, Sackner-Bernstein, C S, Liang, D A, Goldscher, I, Freeman, M L, Kukin, V, Kinhal, J E, Udelson, M, Klapholz, S S, Gottlieb, D, Pearle, R J, Cody, J J, Gregory, N E, Kantrowitz, T H, LeJemtel, S T, Young, M A, Lukas, N H, Shusterman
Publikováno v:
Circulation. 94(11)
Carvedilol has improved the symptomatic status of patients with moderate to severe heart failure in single-center studies, but its clinical effects have not been evaluated in large, multicenter trials.We enrolled 278 patients with moderate to severe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6595c49957bbffac8ea6e41d98735c28
https://pubmed.ncbi.nlm.nih.gov/9495309
https://pubmed.ncbi.nlm.nih.gov/9495309
Autor:
R M, Lang, R, DiBianco, G T, Broderick, S S, Gottlieb, J, Kostis, P A, Lyle, L, Makris, S I, Rajfer, E J, Rucinska
Publikováno v:
American heart journal. 128(3)
Significant decreases in blood pressure (BP) may occur when administration of angiotensin-converting enzyme (ACE) inhibitors is initiated for the treatment of heart failure. The purpose of this study was to compare the safety and tolerability of reco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b497c5b0eb23532ef68f9077d1a02d0d
https://pubmed.ncbi.nlm.nih.gov/8074019
https://pubmed.ncbi.nlm.nih.gov/8074019
Publikováno v:
Circulation. 75(5 Pt 2)
Support for the concept that neurohormonal mechanisms play an important role in determining the survival of patients with severe chronic heart failure is derived from two lines of evidence: circulating levels of neurohormones are markedly elevated in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e08e911c8cf00eaed2fde5bdcc7c1840
https://pubmed.ncbi.nlm.nih.gov/2882867
https://pubmed.ncbi.nlm.nih.gov/2882867
Publikováno v:
Postgraduate medical journal. 62
Although converting-enzyme inhibition is of established value in the management of patients with severe chronic congestive heart failure, troublesome adverse reactions occur frequently during the course of treatment and may cause physicians to interr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4421907f0ed95fc6bb076fbc1219601c
https://pubmed.ncbi.nlm.nih.gov/3022272
https://pubmed.ncbi.nlm.nih.gov/3022272